The phrase "the golden age of biotech" was somewhat popular a few years ago but now seems largely forgotten. Regardless, biotech companies can be excellent long-term investment options for several reasons. Many are highly innovative corporations that develop breakthrough medicines for rare and hard-to-treat ...
motleyfoolusx:regnusx:snyusx:crsp
Image source: The Motley Fool. Sanofi (NASDAQ: SNY) Q1 2024 Earnings Call Apr 25, 2024, 8:30 a.m. ET Paul Hudson Continue reading
motleyfoolusx:sny
